<DOC>
	<DOCNO>NCT00205829</DOCNO>
	<brief_summary>This prospective , single-centre , cross-over study design evaluate safety efficacy use bion , implantable medical device , treatment chronic headache . The clinical study propose determine anticipate adverse event rate treatment outcomes conclusion study . Each trial subject serve his/her control .</brief_summary>
	<brief_title>Bion Occipital Nerve Stimulation</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<criteria>1 . Be diagnose chronic migraine primary chronic daily headache 2 . Have headache characterize pain 3 . Be 18 year age old ; 4 . Be willing able follow studyrelated procedure course study ; 5 . Have exhibit refractoriness two acute medication regimens two prophylactic medication two separate preventive class . 1 . Have receive botulinum toxin ( botox ) injection treatment headache within last 90 day ; 2 . Have previously undergone destructive ganglionectomy 3 . Have previous surgery intend implant area ; 4 . Have ArnoldChiari malformation ; 5 . Have participate within last 30 day plan participate study another device drug trial ; 6 . Be pregnant plan become pregnant study period ; 7 . Have implant electrical device ( e.g. , pacemaker , spinal cord stimulator ) may interfere therapy ; 8 . Demonstrate significant psychological sign , substance abuse symptom , behavioral problem examination and/or history , investigator 's judgment , render inappropriate study ; 9 . Currently require , likely require , diathermy ; 10 . Have medical condition investigator believe would confound study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Chronic headache</keyword>
	<keyword>great occipital nerve stimulation</keyword>
</DOC>